Dr. Srihari’s clinical and research interests are focused on the evaluation and treatment of individuals with psychotic disorders. After completing psychiatry residency training and a fellowship in Schizophrenia at Yale, he joined the staff at the Connecticut Mental Health Center and faculty at Yale in 2005. In 2006, he founded the clinic for Specialized Treatment Early in Psychosis (STEP), which subsequently completed the first U.S. randomized controlled trial to test the effectiveness of a comprehensive model of early intervention. With the benefit of support from the Connecticut Department of Mental Health and Addictions, STEP was able to hire dedicated staff in 2013, and in 2014 initiated a population health approach to model a system of care in southern Connecticut that seeks to engage a broad network of stakeholders in transforming pathways into care for young individuals who are confronting the new onset of a psychotic illness. In 2015, this initiative launched MindMap, a campaign funded by the National Institute of Mental Health (NIMH), that seeks to reduce the duration of untreated psychosis (DUP) in 10 surrounding towns. Dr. Srihari continues to direct the STEP program which now includes an established clinical service, educates students and area providers, and conducts and collaborates in a broad range of research to advance treatments for psychotic illnesses.
“Treatment works: the earlier, the better.”